Penile calciphylaxis: A retrospective case-control study.

Gabel, Colleen; Chakrala, Teja; Shah, Radhika; Danesh, Melissa J; Dobry, Allison S; Garza-Mayers, Anna Cristina; Ko, Lauren N; Nguyen, Emily et al. · J Am Acad Dermatol · 2021

case_control · Level III

Where this comes from

Abstract

Calciphylaxis is a rare disorder characterized by skin necrosis caused by calcium deposition within vessels, thrombosis, and subsequent tissue ischemia. Penile involvement may rarely occur. To identify risk factors, diagnosis, management, and mortality of patients with penile calciphylaxis. A retrospective medical record review was conducted of 16 patients with penile calciphylaxis treated at 2 large urban tertiary care centers between January 2001 and December 2019. A control group of 44 male patients with nonpenile calciphylaxis at the same institution was included. The median survival of patients with penile calciphylaxis was 3.8 months (interquartile range, 27.0 months). Mortality was 50% at 3 months and 62.5% at 6 months for penile calciphylaxis, and 13.6% at 3 months and 29.5% at 6 months for controls (P = .008). Patients with penile calciphylaxis were less likely to be obese (P = .04) but more likely to have hyperparathyroidism (P = .0003) and end-stage renal disease (P = .049). Retrospective study design and small sample size. This study further defines the disease course of penile calciphylaxis, which has high mortality. Imaging may be used to aid diagnosis. Risk factors include end-stage renal disease, hyperparathyroidism, and normal body mass index.

Medical subject headings